Ivy Funds

04/17/2026 | Press release | Distributed by Public on 04/17/2026 12:36

Certificate of Accounting of Securities (Form 40-17F2)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-17f-2
Certificate of Accounting of Securities and Similar
Investments in the Custody of
Management Investment Companies
Pursuant to Rule 17f-2 [17 CFR 270.17f-2]
1. Investment Company Act File Number:
811-06569
Date examination completed:
March 30, 2026
2. State identification Number:
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
PUERTO RICO
3. Exact name of investment company as specified in registration statement:
Ivy Funds
4. Address of principal executive office (number, street, city, state, zip code):
100 Independence, 610 Market Street
Philadelphia, PA 19106-2354
Report of Independent Accountants
To the Board of Trustees of Ivy Funds
We have examined management's assertion, included in the accompanying Management Statement Regarding Compliance with Certain Provisions of the Investment Company Act of 1940, that the fund listed in Appendix A (the "Fund") complied with the requirements of subsections (b) and (c) of Rule 17f-2 under the Investment Company Act of 1940 ("the Act") (the "specified requirements") as of August 15, 2024. The Fund's management is responsible for its assertion and the Fund's compliance with the specified requirements. Our responsibility is to express an opinion on management's assertion about the Fund's compliance with the specified requirements based on our examination.
Our examination was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants. Those standards require that we plan and perform the examination to obtain reasonable assurance about whether management's assertion about compliance with the specified requirements is fairly stated, in all material respects. An examination involves performing procedures to obtain evidence about whether management's assertion is fairly stated in all material respects. The nature, timing and extent of the procedures selected depend on our judgment, including an assessment of the risks of material misstatement of management's assertion, whether due to fraud or error. We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.
Included among our procedures were the following tests performed as of August 15, 2024, and with respect to agreement of security purchases and sales or maturities, for the period from June 30, 2024 (the date of our last examination), through August 15, 2024:
  • Confirmation of all securities held with the sub-transfer agent
  • Reconciliation of all such securities to the books and records of the Fund and sub-transfer agent
  • Agreement of 2 security purchases and 16 security sales since our last report from the books and records of the Fund to the related trade tickets and sub-transfer agent record report
Our examination does not provide a legal determination on the Fund's compliance with the specified requirements.
We are required to be independent and to meet our other ethical responsibilities in accordance with relevant ethical requirements related to the engagement.
In our opinion, management's assertion that Delaware Ivy Wilshire Global Allocation Fund complied with the requirements of subsections (b) and (c) of Rule 17f-2 of the Investment Company Act of 1940 as of August 15, 2024 with respect to securities reflected in the investment account of the Fund is fairly stated, in all material respects.
This report is intended solely for the information and use of management and the Board of Trustees of Ivy Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 30, 2026
PricewaterhouseCoopers LLP, Two Commerce Square, Suite 1800, 2001 Market Street, Philadelphia, PA 19103-7042 T: (267) 330 3000, www.pwc.us
Appendix A
Delaware Ivy Wilshire Global Allocation Fund (1)(2)
  1. Known as Macquarie Global Allocation Fund effective October 29, 2024
  2. On August 22, 2025, the fund was reorganized into Macquarie Balanced Fund (effective December 1, 2025, Macquarie Balanced Fund was renamed Nomura Balanced Fund)
Management Statement Regarding Compliance with Certain
Provisions of the Investment Company Act of 1940
We, as members of management of the Macquarie Global Allocation Fund, a series of Ivy Funds, listed in Appendix A (the "Fund"), are responsible for complying with the requirements of subsections (b) and (c) of Rule 17f-2, Custody of Investments by Registered Management Investment Companies, of the Investment Company Act of 1940. We are also responsible for establishing and maintaining effective internal controls over compliance with those requirements. We have performed an evaluation of the Fund's compliance with the requirements of subsections (b) and (c) of Rule 17f-2 as of August 15, 2024, and for the periods indicated in Appendix A.
Based on this evaluation, we assert that the Fund was in compliance with the requirements of subsections (b) and (c) of Rule 17f-2 of the Investment Company Act of 1940 as of August 15, 2024,, and for the periods indicated in Appendix A, with respect to securities reflected in the investment account of the Fund.
Ivy Funds
By:
/s/RICHARD SALUS

Richard Salus
Senior Vice President and Chief Financial Officer
Date March 30, 2026
/s/DANIEL V. GEATENS

Daniel V. Geatens
Senior Vice President and Treasurer
Date March 30, 2026
Ivy Funds published this content on April 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 17, 2026 at 18:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]